Miscellaneous
The Covid-19 pandemic has brought new risks and challenges for diabetes patients in all aspects of their daily lives, including accessing care and maintaining glycaemic control. So how can clinicians adapt to these challenges and continue to provide optimal care for their patients? To discuss this today we welcome Professor Chantal Mathieu, Professor of Medicine at the KU Leuven and Chair of Endocrinology at the University Hospital Leuven, Belgium. For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn. References: Diabetes UK position statement on support to manage risk for adults living with diabetes from COVID-19. Available at: https://www.diabetes.org.uk/professionals/position-statements-reports/coronavirus-position (last accessed December 2020). Role of technology in diabetes control during COVID-19. Available at: https://www.easd.org/virtualmeeting/home.html#!resources/role-of-technology-in-diabetes-control-during-covid-19 (last accessed December 2020). Garg, et al. Diabetes Technol Ther. 2020(6):431-439 Using the NHS and other health services during coronavirus. Available at: https://www.nhs.uk/conditions/coronavirus-covid-19/social-distancing/using-the-nhs-and-other-health-services/ (last accessed December 2020). Disclosures: Professor Chantal Mathieu has no relevant financial relationships to disclose. Funding statement: This independent educational activity is supported by an educational grant from Eli Lilly, Merck Sharp & Dohme Corp and Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; the financial supporters have had no influence on the content of this education.